All posts by : Felistas

Results from the VITAL randomized controlled trial reveal that vitamin D supplementation helps maintain telomeres, protective caps at the ends of chromosomes that shorten during aging and are linked to the development of certain diseases.

Poor sleep quality is often tied to mental health conditions such as anxiety and depression, but new research from the University of Mississippi suggests it may also be related to how teens feel about their appearance.

For patients with low-risk cervical cancer, survival is similar following simple hysterectomy (SH) versus modified radical hysterectomy (MRH) or radical hysterectomy (RH), according to a study published online May 15 in JAMA Network Open.

An international team of researchers has found a genetic link to long-term symptoms after COVID-19. The identified gene variant is located close to the FOXP4 gene, which is known to affect lung function. The study, published in Nature Genetics, was led by researchers at Karolinska Institutet in Sweden and the Institute for Molecular Medicine in Finland.

A study led by a physician-scientist at the University of Arizona College of Medicine–Tucson’s Sarver Heart Center identified a drug candidate that appears to reverse the progression of a type of heart failure in mouse models, which could lead to expanded treatment options for humans. The results are published in the journal Cell Metabolism.

Researchers from the University of Missouri School of Medicine have shed light on which populations are more likely to be prescribed a high dose of opioid medication. This increases their risk of developing opioid use disorder.

Many grooves and dimples on the surface of the brain are unique to humans, but they’re often dismissed as an uninteresting consequence of packing an unusually large brain into a too-small skull.

A new study led by Profs. Xu Tao and He Shunmin from the Institute of Biophysics of the Chinese Academy of Sciences has revealed how human leukocyte antigen (HLA) genes, central to the immune system, influence both pathogen resistance and susceptibility to autoimmune diseases.

Older adults requiring long-term care frequently experience multiple disabilities, with considerable variation in the combinations of these impairments. Because of this diversity, interventions that focus on a single impairment may not be sufficient. Therefore, understanding the complex physical and cognitive conditions of older adults in need of care is essential for developing appropriate interventions.

Researchers at Sutter’s California Pacific Medical Center (CPMC) in San Francisco, Calif. have discovered early signs of clinical benefit while testing niraparib, a PARP inhibitor, in patients with advanced melanoma whose tumors had specific genetic changes impacting DNA repair.